AOBO Launches New OTC Product To Treat Throat Inflammation

American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").